IPO

3D Rendering futuristic robot technology development artificial intelligence
Biotech

MapLight illuminates $262M IPO plans to fund Cobenfy competitor

MapLight is hoping to raise up to $262 million from its IPO, with the proceeds earmarked for its challenger to Bristol Myers Squibb’s schizophrenia med Cobenfy.
James Waldron Oct 7, 2025 6:30am
IPO initial public offering Wall Street

Big Pharma-backed MapLight plots IPO

Sep 22, 2025 1:57pm
Wall Street stock exchange finance shares share price Nasdaq

LB Pharma upsizes IPO in 1st biotech listing since February

Sep 11, 2025 4:09am
dollars money ocean dollar bill

LB Pharmaceuticals eyes $228M in IPO cash

Sep 8, 2025 3:16pm
Money frozen in ice

CNS biotech attempts to break the IPO ice

Aug 25, 2025 11:10am
heartbeat money acutus IPO

Heartflow pumps up IPO plans to $300M

Aug 6, 2025 11:20am